SAM
AGRX

Sectoral Asset Management’s Agile Therapeutics AGRX Stock Holding History

Sectoral Asset Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23
Closed -$16K – 147
2018
Q3 		$16K Buy
+23
New +$16.8K ﹤0.01% 168

Other funds holding AGRX

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Sectoral Asset Management's AGRX Position: Q4 2018 in Review

Sectoral Asset Management sold out of Agile Therapeutics (AGRX) in Q4 2018, closing a stake of 23 shares — an estimated $16K sold.

Sectoral Asset Management first reported a position in AGRX in Q3 2018 and held it in 1 quarter. The position peaked at $16K in Q3 2018. 25 funds tracked by Wall St. Rank hold AGRX as of Q4 2018.

  • Sectoral Asset Management reported no remaining Agile Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Sectoral Asset Management sold 23 Agile Therapeutics shares in Q4 2018, an estimated $16K.
  • Sectoral Asset Management first reported a position in Agile Therapeutics in Q3 2018 and held it in 1 quarter.
  • Sectoral Asset Management's Agile Therapeutics position peaked at $16K in Q3 2018.
  • 25 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.